Abstract:Background: Salvianic acid A (SAA), a valuable natural product from herbal plant Salvia miltiorrhiza, exhibits excellent antioxidant activities on food industries and efficacious therapeutic potential on cardiovascular diseases. Recently, production of SAA in engineered Escherichia coli was established via the artificial biosynthetic pathway of SAA on the multiple plasmids in our previous work. However, the plasmid-mediated system required to supplement expensive inducers and antibiotics during the fermentation process, restricting scale-up production of SAA. Microbial cell factory would be an attractive approach for constitutive production of SAA by chromosome engineering. Results: The limited enzymatic reactions in SAA biosynthetic pathway from glucose were grouped into three modules, which were sequentially integrated into chromosome of engineered E. coli by λ Red homologous recombination method. With starting strain E. coli BAK5, in which the ptsG, pykF, pykA, pheA and tyrR genes were previously deleted, chassis strain BAK11 was constructed for constitutive production of precursor L-tyrosine by replacing the 17.7-kb mao-paa cluster with module 1 (P lacUV5 -aroG fbr -tyrA fbr -aroE) and the lacI gene with module 2 (P trc -glk-tktA-ppsA). The synthetic 5tacs promoter demonstrated the optimal strength to drive the expression of hpaBC-d-ldh Y52A in module 3, which then was inserted at the position between nupG and speC on the chromosome of strain BAK11. The final strain BKD13 produced 5.6 g/L of SAA by fed-batch fermentation in 60 h from glucose without any antibiotics and inducers supplemented. Conclusions: The plasmid-free and inducer-free strain for SAA production was developed by targeted integration of the constitutive expression of SAA biosynthetic genes into E. coli chromosome. Our work provides the industrial potential for constitutive production of SAA by the indel microbial cell factory and also sets an example of further producing other valuable natural and unnatural products.

Engineering a novel pathway for efficient biosynthesis of salicin in Escherichia coli

Metabolic Engineering of Escherichia coli for High-Level Production of Salicin

Rational and Semirational Approaches for Engineering Salicylate Production in Escherichia coli

Establishment of Novel Biosynthetic Pathways for the Production of Salicyl Alcohol and Gentisyl Alcohol in Engineered Escherichia coli.

Biosynthesis of Salicylic Acid in Plants

The Construction of the Self-Induced Sal System and Its Application in Salicylic Acid Production

Engineering Escherichia coli via introduction of the isopentenol utilization pathway to effectively produce geranyllinalool

Combinatorial Pathway Optimization in Escherichia Coli by Directed Co‐evolution of Rate‐limiting Enzymes and Modular Pathway Engineering

Construction and yield optimization of a cinnamylamine biosynthesis route in Escherichia coli

Design and construction of an artificial pathway for biosynthesis of acetaminophen in Escherichia coli

Optimization of Biosynthetical Conditions of Resveratrol with Recombinant Escherichia coli

Chromosome engineering of Escherichia coli for constitutive production of salvianic acid A

Engineering cascade biocatalysis in whole cells for syringic acid bioproduction

Artificial Biosynthetic Pathway for Efficient Synthesis of Vanillin, a Feruloyl-CoA-Derived Natural Product from Eugenol

De Novo Synthesis of 1-Phenethylisoquinoline in Engineered Escherichia Coli

Metabolic engineering of Saccharomyces cerevisiae for chelerythrine biosynthesis

A facile and efficient synthesis approach of salidroside esters by whole-cell biocatalysts in organic solvents

Unravelling and reconstructing the biosynthetic pathway of bergenin

Metabolic engineering of Escherichia coli for the biosynthesis of α-copaene from glucose

Complete Pathway Elucidation and Heterologous Reconstitution of Rhodiola Salidroside Biosynthesis

Systematic Engineering of Saccharomyces cerevisiae Chassis for Efficient Flavonoid-7- O -Disaccharide Biosynthesis